Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Gardner Russo & Gardner Betting on Beer, Cigarettes, and the Credit Needed to Buy Them

The current round of 13F filings is nearing its conclusion as smart money investors continue to reveal their equity holdings as of March 31. In this article, we are going to take a look at the top stock picks of Tom Russo‘s Gardner Russo & Gardner, which revealed an equity portfolio worth $11.83 billion as of the end of March, with the consumer staples sector representing 56% of that value. The fund primarily invests in large-cap companies and uses external research to complement its in-house research to employ fundamental analysis in seeking out value investments across the globe. Let’s dig deeper into the future prospects of the fund’s top holdings to see if they could serve as valuable ideas for retail investors.

At Insider Monkey, we follow around 800 smart money investors, whose 13F portfolios we analyze quarterly to determine how they are trading thousands of stocks collectively. We identify 15 stocks in the small-cap space using this data as part of our market-beating investment strategy (see more details here).


 – Shares Owned by Gardner Russo & Gardner (as of March 31): 10.83 Million

 – Value of Holding (as of March 31): $846.37 Million

Gardner Russo & Gardner’s Heineken position was cut by 40,000 shares during the first quarter, to 10.83 million shares. Heineken’s first quarter beer volumes rose by 11% year-over-year, with the Asia Pacific region showing the most growth in organic volume, at 23%. A strong Vietnamese and Chinese New Year period and the earlier timing of Easter in 2016 underpinned this trend. HEINEKEN HOLDING EUR1.60 (OTCMKTS:HKHHF)’s shares are up by a little over 3% this year. There were no other investors in our database with positions in Heineken on December 31.

#4 Mastercard Inc (NYSE:MA)

 – Shares Owned by Gardner Russo & Gardner (as of March 31): 9.73 Million

 – Value of Holding (as of March 31): $919.06 Million

Mr. Gardner added about 24,000 Mastercard Inc (NYSE:MA) shares to his fund’s portfolio during the first quarter, with the holding representing 7.77% of its value at the end of March. While Mastercard’s CEO Ajay Banga has sold 50% of his shares this month, it should be stressed that the sale was planned months in advance, rather than being related to a sudden fit of bearishness. Mastercard managed to beat both the top and bottom line-estimates with its financial results for the first quarter, with the company’s worldwide purchase volume growing by 12% year-over-year on a local currency basis. Mastercard Inc (NYSE:MA)’s stock is down by a little over 2% in 2016. Jim Simons‘ renowned managed futures fund Renaissance Technologies was bullish on the $102.8 billion transaction and payment services company during the first quarter, hiking its stake by 16% to 3.50 million shares.

Follow Mastercard Inc (NYSE:MA)
Trade (NYSE:MA) Now!

We’ll have a look at Gardner Russo’s top-3 stock holdings on the next page.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.